| (NOK) | Dec 2025 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | -100.00% |
| Operating expense | — | — |
| Net income | 0.00 | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, LYTIX.OL returned -17.7% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -22.1% |
| 1 year | -17.7% |
| 5 years | -46.5% |
| All-time high | kr 14.40 (Aug 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what kr1,000 in LYTIX.OL would be worth today ›No. Lytix Biopharma ASA has not paid a dividend in the past 12 months.
Lytix Biopharma ASA is part of the Healthcare sector.
Lytix Biopharma ASA has a market cap of 592.13M NOK, based on the latest quote.
Lytix Biopharma ASA is scheduled to report earnings on Aug 27, 2026.
